52W Range | $0.16-$2.41 |
Shares Short | 200 |
Revenue (12 Mos) | $818,000 |
Revenue Growth (YoY) | 248.5% |
Gross Profit (12 Mos) | -$80.5M |
Diluted EPS | -$3.15 |
CEO | Dr. Laura E. Niklason M.D., Ph.D. |
CFO | Mr. Dale A. Sander |
Address | 2525 East North Carolina Highway 54, Durham, NC, United States, 27713 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 218 |